Showing 121 - 140 results of 67,747 for search '(( 05 0 decrease ) OR ( 50 ((((ns decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.88s Refine Results
  1. 121

    GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

    Published 2025
    “…<p>GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ.</p>…”
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…(F) The GluN2B-C456Y mutation decreases the sensitivity to glycine. <i>n</i> = 4 oocytes for WT (EC<sub>50</sub> = 0.38 ± 0.017 μM) and 9 oocytes for C456Y (EC<sub>50</sub> = 1.13 ± 0.049 μM), **<i>P</i> = 0.007, Mann-Whitney. …”
  8. 128
  9. 129

    Adaptation to cool temperature decreases basal and stimulated lipolysis and increases <i>de novo</i> lipogenesis and TAG synthesis. by Hiroyuki Mori (512656)

    Published 2021
    “…<i>n =</i> 5, data are mean ± SD. *<i>p</i> < 0.05. Uncropped western blots are provided in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000988#pbio.3000988.s016" target="_blank">S1 Raw Images</a>, and numerical data for all graphs are provided in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000988#pbio.3000988.s014" target="_blank">S6 Data</a>. …”
  10. 130

    Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

    Published 2024
    “…<p>DRG axon length ratio to pre-treat measured on days 1, 2 and 3 after axonal dieback compound screening with (<b>A</b>) Caps, (<b>C</b>) Pyr, (<b>E</b>) Vcr and (<b>G</b>) Imy in male (left) and female (right) rat DRG explants were compared over time (#p<0.05) and between respective solvent controls (⁕p<0.05). …”
  11. 131
  12. 132

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140